1985
DOI: 10.1128/iai.49.1.141-144.1985
|View full text |Cite
|
Sign up to set email alerts
|

Arachidonic acid facilitates experimental chronic osteomyelitis in rats

Abstract: Arachidonic acid was used as a facilitating agent in experimental rat Staphylococcus aureus osteomyelitis and compared with the more commonly used agent, sodium morrhuate. The injection of arachidonic acid or sodium morrhuate and S. aureus into rat tibiae caused increased quantitative bacterial bone counts, gross bone pathology, roentgenographic changes, and weight loss. The doses required to produce these changes appeared to be lower for arachidonic acid.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

1987
1987
2020
2020

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(11 citation statements)
references
References 13 publications
0
11
0
Order By: Relevance
“…The rat has been a good model for studying intramedullary rodding (15), but it has not been a good model for studying infections as it is difficult to cause infections in rats. Only recently have there been reports indicating that the rat is suitable for studying osteomyelitis in the intact tibia using sodium morrhuate or arachidonic acid similar to that described using the rabbit (17,18). With the exception of these very recent reports, the infection rate, dose of organisms, and type of organisms causing infection are very different in the rat from those in human infections.…”
mentioning
confidence: 99%
“…The rat has been a good model for studying intramedullary rodding (15), but it has not been a good model for studying infections as it is difficult to cause infections in rats. Only recently have there been reports indicating that the rat is suitable for studying osteomyelitis in the intact tibia using sodium morrhuate or arachidonic acid similar to that described using the rabbit (17,18). With the exception of these very recent reports, the infection rate, dose of organisms, and type of organisms causing infection are very different in the rat from those in human infections.…”
mentioning
confidence: 99%
“…In previous animal osteomyelitis models, local injection of vascular sclerosing agent was used to simulate clinical ischemic symptoms. However, there are few patients with osteomyelitis caused by local injection of vascular sclerosing agent into bone tissue [12] . Therefore, there is a gap between the osteomyelitis model made by sclerosing agent and the actual incidence of osteomyelitis, which may lead to changes in the in ammatory pathological mechanism of the bone infection model, which is not conducive to the later study of the treatment of osteomyelitis.…”
Section: Discussionmentioning
confidence: 99%
“…Eighteen rats were randomly divided into 3 groups. Group A: femoral artery ligation + Kirschner needle with S. aureus bio lm internal xation; Group B (positive control, vascular sclerosing agent group [12] ): vascular sclerosing agent + Kirschner needle with S. aureus bio lm internal xation; Group C (blank control): noninfected aseptic operation group and sterile Kirschner needle internal xation.…”
Section: Experiments Groupingmentioning
confidence: 99%
“…Different osteomyelitis experimental models have been proposed in the bibliography using a variety of strategies and agents to induce osseous infection. As an example, authors used morrhuate sodium or its derivative arachidonic acid to induce aseptic osseous necrosis, which is an ideal situation for bacterial proliferation [ 36 ]. The insertion of foreign bodies provides a surface for bacterial adhesion and further biofilm formation, resulting in an increase in bacterial resistance to the host defenses [ 37 ].…”
Section: Discussionmentioning
confidence: 99%